Header Logo

Connection

Maria Papathanasopoulos to Antibodies, Neutralizing

This is a "connection" page, showing publications Maria Papathanasopoulos has written about Antibodies, Neutralizing.
  1. Env-2dCD4 S60C complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1). Vaccine. 2015 Nov 17; 33(46):6298-306.
    View in: PubMed
    Score: 0,420
  2. Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics. Biochem Biophys Res Commun. 2022 07 05; 612:181-187.
    View in: PubMed
    Score: 0,165
  3. Engineering and characterising a novel, highly potent bispecific antibody iMab-CAP256 that targets HIV-1. Retrovirology. 2019 11 08; 16(1):31.
    View in: PubMed
    Score: 0,139
  4. HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6. Virol J. 2022 09 07; 19(1):143.
    View in: PubMed
    Score: 0,042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.